Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

48.63USD
18 Sep 2014
Price Change (% chg)

$2.28 (+4.92%)
Prev Close
$46.35
Open
$47.73
Day's High
$49.08
Day's Low
$46.97
Volume
653,221
Avg. Vol
367,641
52-wk High
$50.37
52-wk Low
$15.77

AGIO.O

Chart for AGIO.O

About

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company’s ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated. The... (more)

Overall

Beta: --
Market Cap (Mil.): $1,597.13
Shares Outstanding (Mil.): 34.46
Dividend: --
Yield (%): --

Financials

  AGIO.O Industry Sector
P/E (TTM): -- 143.76 33.47
EPS (TTM): -2.06 -- --
ROI: -35.87 -2.42 17.39
ROE: -109.01 -7.11 18.25
Search Stocks

Agios leukemia drug shows promise in tiny, early study

- An experimental drug being developed by Agios Pharmaceuticals Inc showed promising anti-cancer activity in a tiny Phase I study of patients with relapsed acute myeloid leukemia (AML), according to data presented on Sunday.

06 Apr 2014

Agios leukemia drug shows promise in tiny, early study

April 6 - An experimental drug being developed by Agios Pharmaceuticals Inc showed promising anti-cancer activity in a tiny Phase I study of patients with relapsed acute myeloid leukemia (AML), according to data presented on Sunday.

06 Apr 2014

Competitors

  Price Change
Pfizer Inc. (PFE.N) $30.58 +0.23
Novartis AG (NOVN.VX) CHF88.45 -0.45
Roche Holding Ltd. (ROG.VX) CHF283.30 +2.50
Sanofi SA (SASY.PA) €88.46 +0.93
AstraZeneca plc (AZN.L) 4,536.50p +43.50
GlaxoSmithKline plc (GSK.L) 1,436.50p +2.50
Eli Lilly and Co (LLY.N) $66.59 +0.68
Shire PLC (SHP.L) 5,320.00p -15.00
Shire PLC (3159084.L) -- --
Alexion Pharmaceuticals, Inc. (ALXN.OQ) $161.56 +0.03

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks